NCT05277051 2025-12-19First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid TumorsGlaxoSmithKlinePhase 1 Recruiting158 enrolled
NCT05980416 2025-11-14Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2Elevation OncologyPhase 1 Terminated88 enrolled 18 charts